The androgen receptor (AR) is a critical regulator of prostate cancer progression and it is increasingly clear that the AR is regulated not only by its cognate steroid hormone, but also by interactions with a constellation of co-regulatory and signaling molecules [1]–[3]. This evidence concerns the gene AR and prostate carcinoma.